Technical Report: Waste Management of Pharmaceuticals in Afghanistan

The current system of waste disposal is viewed as being substantially dysfunctional, with a process timeline measured in years, resulting in large stocks of unviable materials taking valuable pharmaceutical warehouse storage space. The volumes of materials being destroyed are seriously misperceived, giving rise to credibility issues in the efficiency and effectiveness of the supply chain and importing. Public concerns also exist about environmental issues of current destruction procedures. A study was undertaken to collate and analyze the data available on pharmaceutical destruction processes and the items scheduled for destruction. A questionnaire relating to waste management of pharmaceutical issues was developed by a task force of the General Directorate of Pharmaceutical Affairs (GDPA) and used to collect available information at the GDPA and pharmaceutical enterprises. The collected data from the questionnaires is incomplete and at times confusing and contradictory, but it contains enough information to indicate the extent of the problem, identify key problem areas, and contribute to debunking some of the more serious misconceptions concerning waste disposal of pharmaceutical products in Afghanistan. The importance of removing erroneous perceptions on waste disposal of pharmaceutical products needs to be stressed, as these perceptions have proved to be pervasive and enduring. If not checked, they have the power to influence major changes to the medicines supply chain, which would be both wastefully costly and significantly detrimental to its effective operation. The analysis indicates that even if the total nation's pharmaceutical waste is estimated to be around 10% of the total pharmaceutical stock, the actual volume is likely to be much lower, around 2-3%. This discrepancy highlights the need for accurate data collection and analysis to inform policy development and decision-making. The Ministry of Public Health is in the process of formulating an appropriate policy and eventual mechanism for the handling of pharmaceutical items requiring destruction. The study's findings will contribute to this policy development process by providing information on the budgets, range of existing regulations, and scope of materials and volumes requiring destruction. The General Directorate of Pharmaceutical Affairs (GDPA) has been working closely with the Ministry of Public Health to develop a Write-Off Disposal Authorization (WODA) procedure, which will provide a standardized approach to pharmaceutical waste management. The WODA procedure will aim to address the current shortcomings in the pharmaceutical waste management system, including the lack of clear guidelines and procedures for the disposal of pharmaceutical products. The procedure will also aim to improve the efficiency and effectiveness of the supply chain and importing, as well as reduce the environmental impact of current destruction procedures. The development of the WODA procedure is a critical step towards improving the pharmaceutical waste management system in Afghanistan and ensuring the safe and responsible disposal of pharmaceutical products. The study's findings highlight the need for a more accurate and reliable system for tracking and managing pharmaceutical waste. The current system is plagued by inaccuracies and inconsistencies, which can lead to misperceptions and misconceptions about the extent of the problem. The development of a standardized approach to pharmaceutical waste management, such as the WODA procedure, will help to address these issues and provide a more accurate picture of the situation. This will enable the Ministry of Public Health to make informed decisions about policy and resource allocation, and ensure that the pharmaceutical waste management system is operating effectively and efficiently.